Herbs (Global Traditional) · Traditional Chinese Medicine
Polygala (Polygala tenuifolia) (Polygala tenuifolia)
Moderate Evidencebotanical3 PubMed Studies
Hermetica Superfood Encyclopedia
Polygala tenuifolia is a traditional Chinese herb containing bioactive saponins like tenuigenin that enhance hippocampal neurogenesis and synaptic plasticity. The herb demonstrates cognitive benefits primarily through BDNF upregulation and cholinesterase inhibition in brain tissue.
Polygala tenuifolia is a perennial herb native to East Asia, particularly China, where its dried roots (known as Yuan Zhi in traditional Chinese medicine) are harvested as the primary medicinal part. The roots are typically extracted using water, ethanol, or methanol methods to yield crude extracts rich in bioactive compounds, particularly triterpenoid saponins.
A 2024 systematic review and meta-analysis (PMID: 38283842) of 16 RCTs involving 1,103 Alzheimer's disease patients found that Polygala tenuifolia combined with Acorus tatarinowii significantly improved cognitive scores compared to conventional drugs alone. However, no standalone human trials for Polygala tenuifolia were identified, with evidence limited to combination formulas and preclinical models.
Clinical studies used Polygala in herbal combinations without standardized isolated doses reported. Preclinical studies used 2 mg/kg/day intraperitoneally for neurogenesis or up to 1000 mg/kg/day orally in safety studies. Human dosage recommendations are not established from current evidence. Consult a healthcare provider before starting any new supplement.
Polygala tenuifolia (Yuan Zhi) is used as a medicinal herb rather than a nutritional food source, so macronutrient profiling is not standard. The pharmacological value lies in its bioactive compounds concentrated primarily in the root cortex. Key bioactive constituents include: **Triterpenoid saponins (onjisaponins):** Total saponin content ranges from approximately 2–6% of dry root weight, with major compounds including onjisaponin B (tenuifolin is its aglycone/metabolite), onjisaponin F, and polygalasaponins XXXII and XLII; these are considered the primary neuroprotective and expectorant agents. **Xanthones:** Polygalaxanthone III and 1,2,3-trihydroxy-6,7-dimethoxy xanthone, typically present at 0.1–0.5% of dry weight; these contribute to antioxidant and anti-inflammatory activity. **Oligosaccharide esters (tenuifolisides):** Including tenuifoliside A, B, and C, and 3,6'-disinapoyl sucrose (DISS), present at approximately 0.5–2% of dry root; DISS is a key compound studied for antidepressant-like and neuroprotective effects. **Polygalitol:** A cyclitol sugar alcohol found at approximately 1–3% in root tissue. **Acyl sucrose derivatives:** Including sibiricose A5 and A6. **Alkaloids:** Trace amounts of N-acetyl-beta-carboline alkaloids have been identified. **Phenolic acids and flavonoids:** Minor quantities including sucrose-conjugated phenylpropanoids. **Minerals and fiber:** The root contains typical plant-based fiber and trace minerals (calcium, potassium, magnesium, iron), though these are not clinically significant at standard dosing (3–9 g dried root/day in traditional use, or 100–500 mg standardized extract in supplements). **Bioavailability notes:** Triterpenoid saponins have limited oral bioavailability due to extensive first-pass metabolism and hydrolysis by gut microbiota (onjisaponin B is converted to tenuifolin/presenegenin in the GI tract, which is the bioactive circulating form). Gut microbiome composition significantly affects individual pharmacokinetics. Oligosaccharide esters such as DISS show moderate oral absorption. The blood-brain barrier permeability of tenuifolin and xanthone metabolites has been demonstrated in animal models, supporting the observed CNS effects. Co-decoction with Acorus tatarinowii (a traditional pairing) may enhance bioavailability of certain saponin metabolites.
Polygala's primary compounds tenuigenin and polygalasaponins cross the blood-brain barrier to inhibit acetylcholinesterase and enhance BDNF expression in hippocampal neurons. The herb activates CREB signaling pathways that promote synaptic plasticity and neuronal survival. Additionally, polygalasaponins modulate HMG-CoA reductase activity, contributing to lipid metabolism regulation.
Sixteen randomized controlled trials involving 1,103 participants showed that Polygala combined with Acorus tatarinowii improved MMSE scores by 2.57 points in Alzheimer's patients, representing moderate-quality evidence. Most studies were conducted in Chinese populations over 8-24 week periods. Preclinical animal models demonstrate enhanced memory formation and hippocampal neurogenesis, though human studies on Polygala alone remain limited. The evidence base would benefit from larger, longer-duration trials in diverse populations.
Polygala tenuifolia appears well-tolerated in clinical studies with minimal reported adverse effects at standard dosages of 3-9g daily. The herb may potentiate cholinesterase inhibitor medications like donepezil, requiring medical supervision when combined. Gastrointestinal upset including nausea and diarrhea occurs occasionally at higher doses. Safety data during pregnancy and lactation is insufficient, warranting avoidance during these periods.
